2252 — Shanghai MicroPort MedBot Co Balance Sheet
0.000.00%
- HK$21.86bn
- HK$21.68bn
- CNY257.25m
Annual balance sheet for Shanghai MicroPort MedBot Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,497 | 1,941 | 748 | 508 | 612 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 11.2 | 8.04 | 73.3 | 42 | 86.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,515 | 2,094 | 1,099 | 794 | 857 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 38.7 | 361 | 492 | 367 | 297 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,704 | 2,792 | 1,930 | 1,428 | 1,279 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 229 | 234 | 325 | 685 | 503 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 261 | 399 | 512 | 908 | 1,001 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,443 | 2,393 | 1,418 | 519 | 278 |
| Total Liabilities & Shareholders' Equity | 1,704 | 2,792 | 1,930 | 1,428 | 1,279 |
| Total Common Shares Outstanding |